Top 20 global biopharma companies report 3.4% fall in market cap in Q1 2023: GlobalData

Bayer reported the highest market capitalization growth of 23.1% during Q1 2023

Lupin and Exeltis announce reimbursement approval of NaMuscla in Spain

NDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and are characterized by the inability to relax muscles following voluntary contraction (myotonia)

CAPED Trust and AstraZeneca India launch ‘Ganga Godavari Cancer Screening Program’ in Mathura

In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura

DME market across 7MM set to reach $11.1 billion in 2031, forecasts GlobalData

Thermo Fisher Scientific present new innovations to improve biopharmaceutical and proteomics workflows

New mass spectrometry instrument and consumables launch during IMSC 2022

AI to shape future outcomes in cardiovascular care, says GlobalData

AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.

China medical devices market to surpass $42 billion in 2022: GlobalData

Domestic devices are usually preferred over imported medical devices in the national or regional procurement.

TTK Healthcare launches e-Superstore - 'Love Depot'

LoveDepot.com addresses this gap that is yawning in the market

New two-year Deucravacitinib data show promising results for severe plaque psoriasis

Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease

Gut microbiome as a tool in regenerative medicine

Novel approach driven by GN Corp Japan with potentials in neurological illnesses